Literature DB >> 20170987

Application of PC-ANN and PC-LS-SVM in QSAR of CCR1 antagonist compounds: a comparative study.

Mohsen Shahlaei1, Afshin Fassihi, Lotfollah Saghaie.   

Abstract

Principal component regression (PCR), principal component-artificial neural network (PC-ANN), and principal component-least squares-support vector machine (PC-LS-SVM) as regression methods were investigated for building quantitative structure-activity relationships for the prediction of inhibitory activity of some CCR1 antagonists. Nonlinear methods (PC-ANN and PC-LS-SVM) were better than the PCR method considerably in the goodness of fit and predictivity parameters and other criteria for evaluation of the proposed model. These results reflect a nonlinear relationship between the principal components obtained from molecular descriptors and the inhibitory activity of this set of molecules. The maximum variance in activity of the molecules, in PCR method was 45.5%, whereas nonlinear methods, PC-ANN and PC-LS-SVM, could explain more than 93.7% and 95.6% variance in activity data respectively. Copyright (c) 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20170987     DOI: 10.1016/j.ejmech.2009.12.066

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  10 in total

1.  Erratum to: Does being an Olympic city help improve recreational resources? Examining the quality of physical activity resources in a low-income neighborhood of Rio de Janeiro.

Authors:  Fabiana R de Sousa-Mast; Arianne C Reis; Marcelo C Vieira; Sandro Sperandei; Luilma A Gurgel; Uwe Pühse
Journal:  Int J Public Health       Date:  2017-03       Impact factor: 3.380

2.  QSAR study of some 5-methyl/trifluoromethoxy- 1H-indole-2,3-dione-3-thiosemicarbazone derivatives as anti-tubercular agents.

Authors:  M Shahlaei; A Fassihi; A Nezami
Journal:  Res Pharm Sci       Date:  2009-07

Review 3.  Reviewing ligand-based rational drug design: the search for an ATP synthase inhibitor.

Authors:  Chia-Hsien Lee; Hsuan-Cheng Huang; Hsueh-Fen Juan
Journal:  Int J Mol Sci       Date:  2011-08-17       Impact factor: 5.923

4.  A modeling study of aldehyde inhibitors of human cathepsin K using partial least squares method.

Authors:  M Shahlaei; A Fassihi; L Saghaie; E Arkan; A Pourhossein
Journal:  Res Pharm Sci       Date:  2011-07

5.  Quantitative structure activities relationships of some 2-mercaptoimidazoles as CCR2 inhibitors using genetic algorithm-artificial neural networks.

Authors:  L Saghaie; M Shahlaei; A Fassihi
Journal:  Res Pharm Sci       Date:  2013-04

6.  Prediction of partition coefficient of some 3-hydroxy pyridine-4-one derivatives using combined partial least square regression and genetic algorithm.

Authors:  M Shahlaei; A Fassihi; L Saghaie; A Zare
Journal:  Res Pharm Sci       Date:  2014 Mar-Apr

7.  QSAR models for CXCR2 receptor antagonists based on the genetic algorithm for data preprocessing prior to application of the PLS linear regression method and design of the new compounds using in silico virtual screening.

Authors:  Tahereh Asadollahi; Shayessteh Dadfarnia; Ali Mohammad Haji Shabani; Jahan B Ghasemi; Maryam Sarkhosh
Journal:  Molecules       Date:  2011-02-25       Impact factor: 4.411

8.  Quantitative structure-activity relationship study of P2X7 receptor inhibitors using combination of principal component analysis and artificial intelligence methods.

Authors:  Mehdi Ahmadi; Mohsen Shahlaei
Journal:  Res Pharm Sci       Date:  2015 Jul-Aug

9.  Prediction of p38 map kinase inhibitory activity of 3, 4-dihydropyrido [3, 2-d] pyrimidone derivatives using an expert system based on principal component analysis and least square support vector machine.

Authors:  M Shahlaei; L Saghaie
Journal:  Res Pharm Sci       Date:  2014 Nov-Dec

10.  2D-QSAR study of some 2,5-diaminobenzophenone farnesyltransferase inhibitors by different chemometric methods.

Authors:  Saeed Ghanbarzadeh; Saeed Ghasemi; Ali Shayanfar; Heshmatollah Ebrahimi-Najafabadi
Journal:  EXCLI J       Date:  2015-03-30       Impact factor: 4.068

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.